Unknown

Dataset Information

0

Noncanonical WNT Activation in Human Right Ventricular Heart Failure.


ABSTRACT: Background: No medical therapies exist to treat right ventricular (RV) remodeling and RV failure (RVF), in large part because molecular pathways that are specifically activated in pathologic human RV remodeling remain poorly defined. Murine models have suggested involvement of Wnt signaling, but this has not been well-defined in human RVF. Methods: Using a candidate gene approach, we sought to identify genes specifically expressed in human pathologic RV remodeling by assessing the expression of 28 WNT-related genes in the RVs of three groups: explanted nonfailing donors (NF, n = 29), explanted dilated and ischemic cardiomyopathy, obtained at the time of cardiac transplantation, either with preserved RV function (pRV, n = 78) or with RVF (n = 35). Results: We identified the noncanonical WNT receptor ROR2 as transcriptionally strongly upregulated in RVF compared to pRV and NF (Benjamini-Hochberg adjusted P < 0.05). ROR2 protein expression correlated linearly to mRNA expression (R 2 = 0.41, P = 8.1 × 10-18) among all RVs, and to higher right atrial to pulmonary capillary wedge ratio in RVF (R 2 = 0.40, P = 3.0 × 10-5). Utilizing Masson's trichrome and ROR2 immunohistochemistry, we identified preferential ROR2 protein expression in fibrotic regions by both cardiomyocytes and noncardiomyocytes. We compared RVF with high and low ROR2 expression, and found that high ROR2 expression was associated with increased expression of the WNT5A/ROR2/Ca2+ responsive protease calpain-?, cleavage of its target FLNA, and FLNA phosphorylation, another marker of activation downstream of ROR2. ROR2 protein expression as a continuous variable, correlated strongly to expression of calpain-? (R 2 = 0.25), total FLNA (R 2 = 0.67), calpain cleaved FLNA (R 2 = 0.32) and FLNA phosphorylation (R 2 = 0.62, P < 0.05 for all). Conclusion: We demonstrate robust reactivation of a fetal WNT gene program, specifically its noncanonical arm, in human RVF characterized by activation of ROR2/calpain mediated cytoskeleton protein cleavage.

SUBMITTER: Edwards JJ 

PROVIDER: S-EPMC7575695 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications


<b>Background:</b> No medical therapies exist to treat right ventricular (RV) remodeling and RV failure (RVF), in large part because molecular pathways that are specifically activated in pathologic human RV remodeling remain poorly defined. Murine models have suggested involvement of Wnt signaling, but this has not been well-defined in human RVF. <b>Methods:</b> Using a candidate gene approach, we sought to identify genes specifically expressed in human pathologic RV remodeling by assessing the  ...[more]

Similar Datasets

| S-EPMC6482959 | biostudies-literature
| S-EPMC4405709 | biostudies-literature
| S-EPMC9157539 | biostudies-literature
| S-EPMC4556499 | biostudies-literature
2013-06-11 | E-GEOD-47814 | biostudies-arrayexpress
| S-EPMC6601178 | biostudies-literature
2015-04-02 | E-GEOD-67492 | biostudies-arrayexpress
2013-05-06 | E-GEOD-42579 | biostudies-arrayexpress
| S-EPMC3218261 | biostudies-literature
| S-EPMC1890492 | biostudies-literature